EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Venous Thrombogenesis and Cervical Cancer: Plasma MicroRNAs as Prognostic Indicators of Tumor Behavior

Mariana Teixeira Costa, Beatriz Vieira Neto, José Brito da Silva iD, Luísa Carvalho, Lurdes Salgado, Deolinda Pereira, Filomena Adega, Valéria Tavares iD, Rui Medeiros iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mariana Teixeira Costa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Inst…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Circulating MicroRNA, Biomarkers, Tumor, Venous Thromboembolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IPO Porto, Liga Portuguesa Contra o Cancro, Portuguese League Against Cancer—Northern Branch.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer (CC) is the fourth most common cancer among women globally, with venous thromboembolism (VTE) representing a life-threatening complication. Cancer-associated thrombosis (CAT) arises from tumor-driven activation of hemostasis, worsening prognosis. Recently, circulating microRNAs (miRNAs) have emerged as potential biomarkers for both CAT and cervical tumorigenesis. Thus, this study aimed to assess the implications of five miRNAs—miR-20a-5p, -23a-3p, -125b-5p, -145-5p, and -616-3p—in CC-related VTE context. These miRNAs were quantified by RT-qPCR in plasma from 69 CC patients before treatment. Briefly, VTE occurred in nine patients, decreasing overall survival (OS) [log-rank test, p = 0.005; hazard ratio (HR) = 4.78; 95% confidence interval (CI), 1.42–16.05]. Lower miR-20a-5p levels predicted VTE (ꭓ2 test, p = 0.027) and, in subgroup analyses, they were linked to cervical squamous cell carcinoma (CSCC) and older age (ꭓ2 test, p = 0.003 and p = 0.043, respectively). In VTE patients, miR-145-5p downregulation was associated with improved OS (log-rank test, p = 0.018), an effect also observed in the adenocarcinoma (ADC) subgroup (log-rank test, p = 0.039). The remaining miRNAs showed subtype-specific links to clinicopathological features and survival. These findings highlight the potential value of circulating miRNAs in thrombotic risk and prognosis assessment in CC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsCirculating MicroRNABiomarkers, TumorVenous ThromboembolismCarcinoma, Squamous CellPrognosisCarcinogenesisGene Expression Regulation, NeoplasticKaplan-Meier EstimateCervix UteriRetrospective StudiesFollow-Up StudiesHumansFemaleMiddle Aged

Stichwörter der Autor:innen

biomarkerscancer-associated thrombosiscervical cancermicroRNAsprognosisvenous thromboembolism

Substanzen

Circulating MicroRNABiomarkers, Tumor

Autor:innen und Institutionen

  • Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Pathology and Laboratory Medicine Departmen…
  • CytoGenomics Lab, Department of Genetics and Biotechnology, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal.
  • Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal.
  • Oncology Department, Portuguese Institute of Oncology of Porto (IPO Porto), 4200-072 Porto, Portugal.
  • External Radiotherapy Department, Portuguese Institute of Oncology of Porto (IPO Porto), 4200-072 Porto, Portugal.
  • Biosystems and Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, 1749-016 Lisboa, Portugal.

ORCID-Profile: José Brito da Silva, Valéria Tavares, Rui Medeiros

Förderung

  • IPO Porto
  • Liga Portuguesa Contra o Cancro
  • Portuguese League Against Cancer—Northern Branch
  • Fundação para a Ciência e Tecnologia

Zitieren

APA

Costa, M. T., Neto, B. V., da Silva, J. B., Carvalho, L., Salgado, L., Pereira, D., Adega, F., Tavares, V., & Medeiros, R. (2025). Venous Thrombogenesis and Cervical Cancer: Plasma MicroRNAs as Prognostic Indicators of Tumor Behavior. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199796

Vancouver

Costa MT, Neto BV, da Silva JB, Carvalho L, Salgado L, Pereira D, et al. Venous Thrombogenesis and Cervical Cancer: Plasma MicroRNAs as Prognostic Indicators of Tumor Behavior. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199796

BibTeX
@article{Costa2025,
  author = {Costa, Mariana Teixeira and Neto, Beatriz Vieira and da Silva, José Brito and Carvalho, Luísa and Salgado, Lurdes and Pereira, Deolinda and Adega, Filomena and Tavares, Valéria and Medeiros, Rui},
  title = {Venous Thrombogenesis and Cervical Cancer: Plasma MicroRNAs as Prognostic Indicators of Tumor Behavior},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199796}
}
Kostenlos starten →